SLDB

SOLID BIOSCIENCES INC

SLDB·83422E204·US·Common Stock·Healthcare - Biotechnology-Activist

SLDB (SOLID BIOSCIENCES INC) is held by 87 institutional investors as of Q1 2026. Largest holders: RA CAPITAL MANAGEMENT, L.P. ($67.2M), BlackRock, Inc. ($35.7M), Janus Henderson Group Ltd. ($28.9M). Net institutional sentiment: Mixed.

87
Holders
Avg rating(19 Elite)
$336.2M
Total Value
60% (90)
Fund Consensus
50 buying - 33 selling
SLDBSmart Money Verdict
View all
Held by 87 funds
19 elite
Who's Trading
ActivistRA Capital Management, L.P.RA Capital Management, L.P.11.9%Jun 24, 2026
ActivistRDRaymond Debbane10.0%May 5, 2026
ActivistBlackRock, Inc.BlackRock, Inc.4.7%Apr 27, 2026
ActivistRA Capital Management, L.P.RA Capital Management, L.P.9.9%Mar 17, 2026
ActivistPAPerceptive Advisors LLC12.9%Mar 11, 2026
ActivistBSBCLS SB Investco, LP0.0%Mar 10, 2026
InsiderCACumbo AlexanderSell $97KFeb 18, 2026
InsiderHTHowton David TSell $43KFeb 18, 2026
InsiderTKTan KevinSell $31KFeb 18, 2026
InsiderBGBrooks GabrielSellFeb 18, 2026
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
9.3M(+60.7%)$67.2M0.7%+66.37%
60
Increased
5M(+1.8%)$35.7M0.0%+130.84%
29
New
4M$28.9M0.0%+74.83%
40
Increased
3.6M(+77.7%)$26M0.0%+106.95%
44
Decreased
2.6M(-2.5%)$18.7M0.0%+90.15%
0
New
2.4M$17.6M0.0%+74.83%
39
Increased
2.3M(+35.5%)$16.4M0.0%+111.60%
37
Increased
2.2M(+37.1%)$15.8M0.0%+115.76%
37
Decreased
2.1M(-15.1%)$14.8M0.0%+101.91%
0
Increased
1.8M(+25.5%)$12.6M0.0%+59.91%
34
Increased
1.3M(+2.3%)$9.3M0.0%+82.60%
28
Increased
1.1M(+3.5%)$8.1M0.0%+88.33%
28
Increased
956,135(+40.8%)$6.9M0.0%+85.56%
36
Decreased
935,535(-7.0%)$6.7M0.0%+96.53%
0
New
651,216$4.7M0.0%+74.83%
37
Increased
495,076(+56.3%)$3.6M0.0%+112.20%
38
Increased
418,199(+1.3%)$3M0.0%+87.32%
27
Increased
400,292(+1.4%)$2.9M0.0%+121.97%
27
Increased
386,793(+12.3%)$2.8M0.0%+115.71%
30
Increased
363,675(+211.8%)$2.6M0.0%+67.62%
42

Showing 1-20 of 90

1 / 5

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used